Clinical Trials Directory

Trials / Completed

CompletedNCT03073980

Assessing Efficacy of Intravenous Acetaminophen for Perioperative Pain Control for Oocyte Retrieval

Assessing Efficacy of Intravenous Acetaminophen for Perioperative Pain Control for Oocyte Retrieval: a Randomized, Double Blind, Placebo-controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
161 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
Female
Age
18 Years – 44 Years
Healthy volunteers
Accepted

Summary

In this research study we want to learn more about how effective certain medications are at reducing pain after oocyte (egg) retrieval surgery and how effective they are at reducing the time between the retrieval and discharge from the hospital. We will compare three types of pre-operative medications: intravenous (IV) acetaminophen, oral (PO) acetaminophen, and placebo (no medication), which is the current typical care.

Detailed description

OBJECTIVE: To compare the efficacy of pre-operative IV acetaminophen, PO acetaminophen, versus placebo for adjunctive pain control in the setting of oocyte retrieval in an in vitro fertilization clinic setting. HYPOTHESIS: Our hypothesis is that patients receiving IV acetaminophen pre-operatively will have improved postoperative pain scores, lower overall opiate consumption, and shortened time to discharge from post analgesic recovery unit (PACU) or recovery than those receiving PO acetaminophen or placebo. Participants will be consented and enrolled in the study prior to their oocyte retrieval. The patient will then be randomized to one of three treatments: Group 1: In the pre-op suite, these patients will receive 1000mg IV acetaminophen and PO placebo, followed by standard protocol anesthesia and pain control as needed. Group 2: In the pre-op suite, these patients will receive 1000mg PO acetaminophen and IV placebo, followed by standard protocol anesthesia and pain control as needed. Group 3: In the pre-op suite, these patients will receive PO and IV placebo, followed by standard protocol anesthesia and pain control as needed. The patient and care team will be blinded to the treatment group. A member of the study staff will review participants' medical record to collect data regarding demographics, clinical history, cycle and pregnancy outcomes, up to 12 months following study completion.

Conditions

Interventions

TypeNameDescription
DRUGIV AcetaminophenIV Acetaminophen for pain control during procedure
DRUGPO AcetaminophenPO Acetaminophen for pain control during procedure
OTHERPlacebo IV AcetaminophenPlacebo IV Acetaminophen
OTHERPlacebo PO AcetaminophenPlacebo PO Acetaminophen

Timeline

Start date
2019-09-01
Primary completion
2020-11-01
Completion
2020-12-01
First posted
2017-03-08
Last updated
2022-05-26
Results posted
2022-04-20

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03073980. Inclusion in this directory is not an endorsement.